Pregabalin is widely used in neurology, psychiatry and primary healthcare, and recently in literature different studies explain the possible misuse [1Schifano F. SSP 2014 ;

Haga clic aquí para ir a la sección de Referencias, 2Schifano F., y al. SSP 2011 ;

Haga clic aquí para ir a la sección de Referencias]. Pregabalin has shown greater potency in preclinical models of epilepsy, pain and anxiety, and may have potential in the treatment of cocaine addiction [3de Guglielmo G., y al. SSP 2013 ;

Haga clic aquí para ir a la sección de Referencias]. The purpose of this report is to review the clinical evidence for the potential of abuse and misuse of pregabalin. We propose ten different cases and literature review.

Ten inpatients with misuse of pregabalin were assessed with: the SCID-P, Anamnestic Folio, HAM-A and DAST. We conducted a systematic review of the literature (PubMed, Embase, PsychInfo), using the terms “pregabalin”, “misuse”.

All our patients present: cocaine, alcohol and/heroin positive in drugs urine screening at admission; a significant high level of total anxiety at the HAM-A Tot (P<.001), and especially at the item 7 (P<.001); the misuse of pregabalin is made for sniffing; the predominant symptoms assessed were euphoria, psychomotor activation and sedation.

Schifano F et al., [1Schifano F. SSP 2014 ;

Haga clic aquí para ir a la sección de Referencias, 2Schifano F., y al. SSP 2011 ;

Haga clic aquí para ir a la sección de Referencias] suggest that pregabalin should carefully prescribe in patients with a possible previous history of drug abuse. Our result identifies a particular population the misuse pregabalin that are abuser of cocaine, alcohol and/or heroin. Further research is warranted to replicate our clinical and qualitative observations and, in general, quantitative studies in large samples followed up over time are needed. Methodological limitations, clinical implications and suggestions for future research directions are considered.